Compugen Stock Investor Sentiment

CGEN Stock  USD 1.84  0.09  4.66%   
About 54% of Compugen's investor base is interested to short. The analysis of overall sentiment of trading Compugen stock suggests that many investors are impartial at this time. Compugen's investing sentiment overview a quick insight into current market opportunities from investing in Compugen. Many technical investors use Compugen stock news signals to limit their universe of possible portfolio assets and to time the market correctly.

Comfort Level 46

 Impartial

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Compugen's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Compugen.

Compugen Historical Sentiment

Although Compugen's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Compugen, such as negative comments on social media and news outlets, may cause fear in the market and push Compugen's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Compugen.

Compugen Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Compugen can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Compugen Historical Investor Sentiment

Investor biases related to Compugen's public news can be used to forecast risks associated with an investment in Compugen. The trend in average sentiment can be used to explain how an investor holding Compugen can time the market purely based on public headlines and social activities around Compugen. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Compugen's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Compugen and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Compugen news discussions. The higher the estimate score, the more favorable the investor's outlook on Compugen.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of Compugen's Stock prices. Below is the latest headlines and news related to Compugen Stock. The global stock market is bullish. About 62% of major world exchanges and indexes are currently up. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about Compugen that are available to investors today. This information is accessible both publicly - through Compugen's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Compugen-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Compugen news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Compugen relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Compugen's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Compugen alpha.

Compugen Largest EPS Surprises

Earnings surprises can significantly impact Compugen's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2011-11-08
2011-09-30-0.09-0.1-0.0111 
2011-05-11
2011-03-31-0.07-0.060.0114 
2010-02-09
2009-12-31-0.08-0.070.0112 
2009-10-27
2009-09-30-0.07-0.060.0114 
2025-08-06
2025-06-30-0.06-0.08-0.0233 
2023-11-07
2023-09-30-0.09-0.11-0.0222 
View All Earnings Estimates
few days ago at finance.yahoo.com         
Compugen Partners with AXL to Support Canadas AI Commercialization
Yahoo News
over a week ago at news.google.com         
Compugen Stock Price Passes Above 200 Day Moving Average - Whats Next - MarketBeat
Google News at Macroaxis
over two weeks ago at news.google.com         
Update Recap Can Compugen Ltd stock continue upward trend - Portfolio Value Report Smart Money Movem...
Google News at Macroaxis
over two weeks ago at news.google.com         
Why Compugen Ltd. stock could benefit from AI revolution - Rate Cut Intraday High Probability Alerts...
Google News at Macroaxis
over three weeks ago at thelincolnianonline.com         
Compugen Coverage Initiated by Analysts at HC Wainwright
news
over three weeks ago at news.google.com         
H.C. Wainwright initiates coverage on Compugen stock with Buy rating - Investing.com
Google News at Macroaxis
over three weeks ago at globenewswire.com         
TIGIT Inhibitors Drugs Clinical Trials Global Market Opportunity Report 2026-2030 Roche, Gilead Scie...
Macroaxis News: globenewswire.com
over a month ago at news.google.com         
Will Compugen Ltd. stock benefit from sector rotation - Weekly Profit Summary Daily Growth Stock Tip...
Google News at Macroaxis
over a month ago at news.google.com         
Compugen Secures 90 Million in a Strategic Royalty Monetization Deal with AstraZeneca - The Globe an...
Google News at Macroaxis
over a month ago at seekingalpha.com         
Compugen rises on royalty deal with AstraZeneca
seekingalpha News
over a month ago at prnewswire.com         
Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to 90 Million
prnewswire News
over a month ago at finance.yahoo.com         
Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to 90 Million
Yahoo News
over two months ago at news.google.com         
Compugen Share Price Passes Above 200 Day Moving Average - Time to Sell - MarketBeat
Google News at Macroaxis
over two months ago at news.google.com         
Compugen Price Target Decreased by 10.71 percent to 6.38 - MSN
Google News at Macroaxis
over two months ago at news.google.com         
How interest rate cuts could boost Compugen Ltd. stock - July 2025 PostEarnings Safe Entry Zone Tips...
Google News at Macroaxis
There is far too much social signal, news, headlines, and media speculation about Compugen that are available to investors today. This information is accessible both publicly - through Compugen's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Compugen-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Compugen news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Compugen relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Compugen's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Compugen alpha.

Compugen Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Compugen Ltd Q3 2025 Earnings Report Preview What To Expect
11/07/2025
2
Compugen Q3 Earnings Snapshot
11/10/2025
3
Compugen Ltd. Q3 2025 Earnings Call Transcript
11/11/2025
4
Compugen Launches Business Unit to Help Canadian Organizations Maximize Value on Microsoft Investments
11/13/2025
5
Compugen Raised to Hold at Wall Street Zen
11/17/2025
6
Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to 90 Million
12/17/2025
7
TIGIT Inhibitors Drugs Clinical Trials Global Market Opportunity Report 2026-2030 Roche, Gilead Sciences, Merck, Arcus Biosciences, Compugen, and Vir Biotechnol...
01/06/2026
8
Compugen Partners with AXL to Support Canadas AI Commercialization
01/26/2026
When determining whether Compugen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Compugen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Compugen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Compugen Stock:
Check out
To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Will Life Sciences Tools & Services sector continue expanding? Could Compugen diversify its offerings? Factors like these will boost the valuation of Compugen. Projected growth potential of Compugen fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Compugen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.30)
Revenue Per Share
0.075
Quarterly Revenue Growth
(0.89)
Return On Assets
(0.18)
Return On Equity
(0.53)
Investors evaluate Compugen using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Compugen's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Compugen's market price to deviate significantly from intrinsic value.
It's important to distinguish between Compugen's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Compugen should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Compugen's market price signifies the transaction level at which participants voluntarily complete trades.